APO Research
Talk to an analyst

APO RESEARCH · REPORT

Constipation Treatment

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Constipation Treatment Market Outlook and Growth Opportunities 2026

20 December 2025193 pages

Choose your research edition.

Industry ResearchConstipation Treatment Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Constipation Treatment Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Constipation Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Constipation Treatment Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Constipation Treatment Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Constipation Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Constipation Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Constipation Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Constipation Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Constipation Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Constipation Treatment market include Abbott, Takeda, Sanofi, Bayer, AstraZeneca, Sucampo Pharmaceuticals, Shionogi, SGYP and Renexxion, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Constipation Treatment market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Constipation Treatment and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Constipation Treatment revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Constipation Treatment market.

Constipation Treatment Segment by Company

Abbott

Takeda

Sanofi

Bayer

AstraZeneca

Sucampo Pharmaceuticals

Shionogi

SGYP

Renexxion

Prestige Brands

Janssen Pharmaceutical

Ironwood Pharmaceuticals

Daewoong

Cosmo Pharmaceuticals

Albireo Pharma

Constipation Treatment Segment by Type

Opioid Induced Constipation

Irritable Bowel Syndrome with Constipation

Chronic Idiopathic Constipation

Constipation Treatment Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Constipation Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Constipation Treatment status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Constipation Treatment key companies, revenue, market share, and recent developments.

3. To split the Constipation Treatment breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Constipation Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Constipation Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze Constipation Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Constipation Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Constipation Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Constipation Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Constipation Treatment industry.

Chapter 3: Detailed analysis of Constipation Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Constipation Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Constipation Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Constipation Treatment Industry Trends Table 2. Constipation Treatment Industry Drivers Table 3. Constipation Treatment Industry Opportunities and Challenges Table 4. Constipation Treatment Industry Restraints Table 5. Global Constipation Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Constipation Treatment Revenue Share by Company (2021-2026) Table 7. Global Constipation Treatment Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Constipation Treatment Key Company Manufacturing Base & Headquarters Table 9. Global Constipation Treatment Company, Product Type & Application Table 10. Global Constipation Treatment Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Constipation Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Opioid Induced Constipation Table 15. Significant Companies of Irritable Bowel Syndrome with Constipation Table 16. Significant Companies of Chronic Idiopathic Constipation Table 17. Global Constipation Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Constipation Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Constipation Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Constipation Treatment Sales Value Share by Type (2021-2026) Table 21. Global Constipation Treatment Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospital Pharmacies Table 23. Significant Companies of Online Pharmacies Table 24. Significant Companies of Retail Pharmacies Table 25. Global Constipation Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Constipation Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Constipation Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Constipation Treatment Sales Value Share by Application (2021-2026) Table 29. Global Constipation Treatment Sales Value Share by Application (2027-2032) Table 30. Global Constipation Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Constipation Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Constipation Treatment Sales Value Share by Region (2021-2026) Table 33. Global Constipation Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Constipation Treatment Sales Value Share by Region (2027-2032) Table 35. Global Constipation Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Constipation Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Constipation Treatment Sales Value Market Share by Country (2021-2026) Table 38. Global Constipation Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Constipation Treatment Sales Value Market Share by Country (2027-2032) Table 40. Abbott Company Information Table 41. Abbott Business Overview Table 42. Abbott Constipation Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Abbott Constipation Treatment Product Portfolio Table 44. Abbott Recent Development Table 45. Takeda Company Information Table 46. Takeda Business Overview Table 47. Takeda Constipation Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Takeda Constipation Treatment Product Portfolio Table 49. Takeda Recent Development Table 50. Sanofi Company Information Table 51. Sanofi Business Overview Table 52. Sanofi Constipation Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Sanofi Constipation Treatment Product Portfolio Table 54. Sanofi Recent Development Table 55. Bayer Company Information Table 56. Bayer Business Overview Table 57. Bayer Constipation Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Bayer Constipation Treatment Product Portfolio Table 59. Bayer Recent Development Table 60. AstraZeneca Company Information Table 61. AstraZeneca Business Overview Table 62. AstraZeneca Constipation Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. AstraZeneca Constipation Treatment Product Portfolio Table 64. AstraZeneca Recent Development Table 65. Sucampo Pharmaceuticals Company Information Table 66. Sucampo Pharmaceuticals Business Overview Table 67. Sucampo Pharmaceuticals Constipation Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Sucampo Pharmaceuticals Constipation Treatment Product Portfolio Table 69. Sucampo Pharmaceuticals Recent Development Table 70. Shionogi Company Information Table 71. Shionogi Business Overview Table 72. Shionogi Constipation Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Shionogi Constipation Treatment Product Portfolio Table 74. Shionogi Recent Development Table 75. SGYP Company Information Table 76. SGYP Business Overview Table 77. SGYP Constipation Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. SGYP Constipation Treatment Product Portfolio Table 79. SGYP Recent Development Table 80. Renexxion Company Information Table 81. Renexxion Business Overview Table 82. Renexxion Constipation Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Renexxion Constipation Treatment Product Portfolio Table 84. Renexxion Recent Development Table 85. Prestige Brands Company Information Table 86. Prestige Brands Business Overview Table 87. Prestige Brands Constipation Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Prestige Brands Constipation Treatment Product Portfolio Table 89. Prestige Brands Recent Development Table 90. Janssen Pharmaceutical Company Information Table 91. Janssen Pharmaceutical Business Overview Table 92. Janssen Pharmaceutical Constipation Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Janssen Pharmaceutical Constipation Treatment Product Portfolio Table 94. Janssen Pharmaceutical Recent Development Table 95. Ironwood Pharmaceuticals Company Information Table 96. Ironwood Pharmaceuticals Business Overview Table 97. Ironwood Pharmaceuticals Constipation Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Ironwood Pharmaceuticals Constipation Treatment Product Portfolio Table 99. Ironwood Pharmaceuticals Recent Development Table 100. Daewoong Company Information Table 101. Daewoong Business Overview Table 102. Daewoong Constipation Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Daewoong Constipation Treatment Product Portfolio Table 104. Daewoong Recent Development Table 105. Cosmo Pharmaceuticals Company Information Table 106. Cosmo Pharmaceuticals Business Overview Table 107. Cosmo Pharmaceuticals Constipation Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Cosmo Pharmaceuticals Constipation Treatment Product Portfolio Table 109. Cosmo Pharmaceuticals Recent Development Table 110. Albireo Pharma Company Information Table 111. Albireo Pharma Business Overview Table 112. Albireo Pharma Constipation Treatment Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Albireo Pharma Constipation Treatment Product Portfolio Table 114. Albireo Pharma Recent Development Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Constipation Treatment Product Image Figure 2. Global Constipation Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Constipation Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Constipation Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Opioid Induced Constipation Image Figure 8. Irritable Bowel Syndrome with Constipation Image Figure 9. Chronic Idiopathic Constipation Image Figure 10. Global Constipation Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Constipation Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Constipation Treatment Sales Value Share by Type (2021-2032) Figure 13. Hospital Pharmacies Image Figure 14. Online Pharmacies Image Figure 15. Retail Pharmacies Image Figure 16. Global Constipation Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Constipation Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Constipation Treatment Sales Value Share by Application (2021-2032) Figure 19. Global Constipation Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Constipation Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Constipation Treatment Sales Value (2021-2032) & (US$ Million) Figure 22. North America Constipation Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Constipation Treatment Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Constipation Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Constipation Treatment Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Constipation Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Constipation Treatment Sales Value (2021-2032) & (US$ Million) Figure 28. South America Constipation Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Constipation Treatment Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Constipation Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Constipation Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Constipation Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Constipation Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Opioid Induced Constipation
  • Irritable Bowel Syndrome with Constipation
  • Chronic Idiopathic Constipation
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Abbott
  • Takeda
  • Sanofi
  • Bayer
  • AstraZeneca
  • Sucampo Pharmaceuticals
  • Shionogi
  • SGYP
  • Renexxion
  • Prestige Brands
  • Janssen Pharmaceutical
  • Ironwood Pharmaceuticals
  • Daewoong
  • Cosmo Pharmaceuticals
  • Albireo Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Constipation Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Constipation Treatment Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Constipation Treatment Market Dynamics
  1. 2.1 Constipation Treatment Industry Trends
  2. 2.2 Constipation Treatment Industry Drivers
  3. 2.3 Constipation Treatment Industry Opportunities and Challenges
  4. 2.4 Constipation Treatment Industry Restraints
3 Constipation Treatment Market by Company
  1. 3.1 Global Constipation Treatment Company Revenue Ranking in 2025
  2. 3.2 Global Constipation Treatment Revenue by Company (2021-2026)
  3. 3.3 Global Constipation Treatment Company Ranking (2024-2026)
  4. 3.4 Global Constipation Treatment Company Manufacturing Base and Headquarters
  5. 3.5 Global Constipation Treatment Company Product Type and Application
  6. 3.6 Global Constipation Treatment Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Constipation Treatment Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Constipation Treatment Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Constipation Treatment Market by Type
  1. 4.1 Constipation Treatment Type Introduction
  2. 4.1.1 Opioid Induced Constipation
  3. 4.1.2 Irritable Bowel Syndrome with Constipation
  4. 4.1.3 Chronic Idiopathic Constipation
  5. 4.2 Global Constipation Treatment Sales Value by Type
  6. 4.2.1 Global Constipation Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Constipation Treatment Sales Value by Type (2021-2032)
  8. 4.2.3 Global Constipation Treatment Sales Value Share by Type (2021-2032)
5 Constipation Treatment Market by Application
  1. 5.1 Constipation Treatment Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Constipation Treatment Sales Value by Application
  6. 5.2.1 Global Constipation Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Constipation Treatment Sales Value by Application (2021-2032)
  8. 5.2.3 Global Constipation Treatment Sales Value Share by Application (2021-2032)
6 Constipation Treatment Regional Value Analysis
  1. 6.1 Global Constipation Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Constipation Treatment Sales Value by Region (2021-2032)
  3. 6.2.1 Global Constipation Treatment Sales Value by Region: 2021-2026
  4. 6.2.2 Global Constipation Treatment Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Constipation Treatment Sales Value (2021-2032)
  7. 6.3.2 North America Constipation Treatment Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Constipation Treatment Sales Value (2021-2032)
  10. 6.4.2 Europe Constipation Treatment Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Constipation Treatment Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Constipation Treatment Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Constipation Treatment Sales Value (2021-2032)
  16. 6.6.2 South America Constipation Treatment Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Constipation Treatment Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Constipation Treatment Sales Value Share by Country, 2025 VS 2032
7 Constipation Treatment Country-level Value Analysis
  1. 7.1 Global Constipation Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Constipation Treatment Sales Value by Country (2021-2032)
  3. 7.2.1 Global Constipation Treatment Sales Value by Country (2021-2026)
  4. 7.2.2 Global Constipation Treatment Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Constipation Treatment Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Constipation Treatment Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Constipation Treatment Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Constipation Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Constipation Treatment Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Constipation Treatment Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Constipation Treatment Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Constipation Treatment Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Constipation Treatment Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Constipation Treatment Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Constipation Treatment Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Constipation Treatment Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Constipation Treatment Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Constipation Treatment Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Constipation Treatment Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Constipation Treatment Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Constipation Treatment Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Constipation Treatment Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Constipation Treatment Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Constipation Treatment Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Constipation Treatment Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Constipation Treatment Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Constipation Treatment Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Constipation Treatment Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Constipation Treatment Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Constipation Treatment Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Constipation Treatment Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Constipation Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Constipation Treatment Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Constipation Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Constipation Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Constipation Treatment Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Constipation Treatment Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Takeda
  8. 8.2.1 Takeda Company Information
  9. 8.2.2 Takeda Business Overview
  10. 8.2.3 Takeda Constipation Treatment Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Takeda Constipation Treatment Product Portfolio
  12. 8.2.5 Takeda Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Constipation Treatment Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Constipation Treatment Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Bayer
  20. 8.4.1 Bayer Company Information
  21. 8.4.2 Bayer Business Overview
  22. 8.4.3 Bayer Constipation Treatment Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bayer Constipation Treatment Product Portfolio
  24. 8.4.5 Bayer Recent Developments
  25. 8.5 AstraZeneca
  26. 8.5.1 AstraZeneca Company Information
  27. 8.5.2 AstraZeneca Business Overview
  28. 8.5.3 AstraZeneca Constipation Treatment Revenue and Gross Margin (2021-2026)
  29. 8.5.4 AstraZeneca Constipation Treatment Product Portfolio
  30. 8.5.5 AstraZeneca Recent Developments
  31. 8.6 Sucampo Pharmaceuticals
  32. 8.6.1 Sucampo Pharmaceuticals Company Information
  33. 8.6.2 Sucampo Pharmaceuticals Business Overview
  34. 8.6.3 Sucampo Pharmaceuticals Constipation Treatment Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sucampo Pharmaceuticals Constipation Treatment Product Portfolio
  36. 8.6.5 Sucampo Pharmaceuticals Recent Developments
  37. 8.7 Shionogi
  38. 8.7.1 Shionogi Company Information
  39. 8.7.2 Shionogi Business Overview
  40. 8.7.3 Shionogi Constipation Treatment Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shionogi Constipation Treatment Product Portfolio
  42. 8.7.5 Shionogi Recent Developments
  43. 8.8 SGYP
  44. 8.8.1 SGYP Company Information
  45. 8.8.2 SGYP Business Overview
  46. 8.8.3 SGYP Constipation Treatment Revenue and Gross Margin (2021-2026)
  47. 8.8.4 SGYP Constipation Treatment Product Portfolio
  48. 8.8.5 SGYP Recent Developments
  49. 8.9 Renexxion
  50. 8.9.1 Renexxion Company Information
  51. 8.9.2 Renexxion Business Overview
  52. 8.9.3 Renexxion Constipation Treatment Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Renexxion Constipation Treatment Product Portfolio
  54. 8.9.5 Renexxion Recent Developments
  55. 8.10 Prestige Brands
  56. 8.10.1 Prestige Brands Company Information
  57. 8.10.2 Prestige Brands Business Overview
  58. 8.10.3 Prestige Brands Constipation Treatment Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Prestige Brands Constipation Treatment Product Portfolio
  60. 8.10.5 Prestige Brands Recent Developments
  61. 8.11 Janssen Pharmaceutical
  62. 8.11.1 Janssen Pharmaceutical Company Information
  63. 8.11.2 Janssen Pharmaceutical Business Overview
  64. 8.11.3 Janssen Pharmaceutical Constipation Treatment Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Janssen Pharmaceutical Constipation Treatment Product Portfolio
  66. 8.11.5 Janssen Pharmaceutical Recent Developments
  67. 8.12 Ironwood Pharmaceuticals
  68. 8.12.1 Ironwood Pharmaceuticals Company Information
  69. 8.12.2 Ironwood Pharmaceuticals Business Overview
  70. 8.12.3 Ironwood Pharmaceuticals Constipation Treatment Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Ironwood Pharmaceuticals Constipation Treatment Product Portfolio
  72. 8.12.5 Ironwood Pharmaceuticals Recent Developments
  73. 8.13 Daewoong
  74. 8.13.1 Daewoong Company Information
  75. 8.13.2 Daewoong Business Overview
  76. 8.13.3 Daewoong Constipation Treatment Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Daewoong Constipation Treatment Product Portfolio
  78. 8.13.5 Daewoong Recent Developments
  79. 8.14 Cosmo Pharmaceuticals
  80. 8.14.1 Cosmo Pharmaceuticals Company Information
  81. 8.14.2 Cosmo Pharmaceuticals Business Overview
  82. 8.14.3 Cosmo Pharmaceuticals Constipation Treatment Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Cosmo Pharmaceuticals Constipation Treatment Product Portfolio
  84. 8.14.5 Cosmo Pharmaceuticals Recent Developments
  85. 8.15 Albireo Pharma
  86. 8.15.1 Albireo Pharma Company Information
  87. 8.15.2 Albireo Pharma Business Overview
  88. 8.15.3 Albireo Pharma Constipation Treatment Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Albireo Pharma Constipation Treatment Product Portfolio
  90. 8.15.5 Albireo Pharma Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst